Kenvue (KVUE) Stock Forecast & Price Target

$22.93

+0.01 (+0.04%)

(As of 10/22/2024 ET)

Kenvue - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Hold

Based on 12 Analyst Ratings

Sell
1

Hold
7

Buy
4

Based on 12 Wall Street analysts who have issued ratings for Kenvue in the last 12 months, the stock has a consensus rating of "Hold." Out of the 12 analysts, 1 has given a sell rating, 7 have given a hold rating, and 4 have given a buy rating for KVUE.

Consensus Price Target

$22.64
-1.28% Downside

According to the 12 analysts' twelve-month price targets for Kenvue, the average price target is $22.64. The highest price target for KVUE is $27.00, while the lowest price target for KVUE is $18.00. The average price target represents a forecasted downside of -1.28% from the current price of $22.93.

KVUE Analyst Ratings Over Time

Type	Current Forecast 10/24/23 to 10/23/24	1 Month Ago 9/24/23 to 9/23/24	3 Months Ago 7/26/23 to 7/25/24	1 Year Ago 10/24/22 to 10/24/23
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	4 Buy rating(s)	3 Buy rating(s)	6 Buy rating(s)	8 Buy rating(s)
Hold	7 Hold rating(s)	6 Hold rating(s)	7 Hold rating(s)	5 Hold rating(s)
Sell	1 Sell rating(s)	1 Sell rating(s)	1 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$22.64	$21.56	$22.45	$27.55
Forecasted Upside	-1.28% Downside	-6.36% Downside	23.04% Upside	37.87% Upside
Consensus Rating	Hold	Hold	Hold	Moderate Buy

Watch this before it gets removed (Ad)

If you missed it, my emergency election broadcast is now available - but will be removed soon

Click here to watch it now.

KVUE Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

KVUE Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Kenvue Stock vs. The Competition

Type	Kenvue	Consumer Staples Companies	S&P 500
Consensus Rating Score	2.25	2.43	2.50
Consensus Rating	Hold	Hold	Hold
Predicted Upside	-1.28% Downside	127.92% Upside	7.94% Upside
News Sentiment Rating	Positive News See Recent KVUE News	Neutral News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
10/22/2024	Bank of America 4 of 5 stars		Boost Target	Buy ➝ Buy	$24.00 ➝ $27.00	+18.11%
10/11/2024	JPMorgan Chase & Co. 2 of 5 stars		Boost Target	Overweight ➝ Overweight	$24.00 ➝ $25.00	+17.15%
9/24/2024	Jefferies Financial Group 2 of 5 stars		Initiated Coverage	Buy	$27.00	+17.29%
9/24/2024	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	N. Modi Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Outperform ➝ Sector Perform	$24.00	+4.26%
9/23/2024	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Neutral ➝ Neutral	$20.00 ➝ $21.00	-8.77%
8/7/2024	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$23.00 ➝ $24.00	+14.72%
Next opportunity for crypto millions (Ad) According to Steven Lubka, head of a private equity firm with over $250M in assets under management, "Bitcoin is poised to reach six-figures, no matter who wins the U.S. presidential election…" And as Bitcoin rallies, we could see other smaller coins rise to heights never seen before. Coins that you may not have even heard of before could shoot up 10x, 20x, maybe even 150x in the coming months… Just click here to request my "Bull Run Millionaire Blueprint" now.
8/7/2024	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Neutral ➝ Neutral	$20.00 ➝ $22.00	+5.36%
7/10/2024	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Neutral ➝ Neutral	$21.00 ➝ $20.00	+13.06%
5/8/2024	HSBC Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Hold ➝ Hold	$20.00 ➝ $21.00	+3.09%
4/11/2024	Sanford C. Bernstein Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Underperform	$18.00	-11.02%
4/3/2024	William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Andersen Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Market Perform
3/1/2024	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Buy ➝ Neutral	$20.00	+5.24%
9/7/2023	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Buy	$28.00	+25.06%
9/6/2023	Argus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Hold
7/25/2023	Edward Jones Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Buy
5/30/2023	BNP Paribas Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Neutral	$28.00	+6.46%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 05:15 AM ET.

Should I Buy Kenvue Stock? KVUE Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Wednesday, October 16, 2024. Please send any questions or comments about these Kenvue pros and cons to contact@marketbeat.com.

Kenvue
Bull Case

Here are some ways that investors could benefit from investing in Kenvue Inc.:

Kenvue Inc. has recently increased its dividend from $0.20 to $0.205 per share, indicating a positive outlook on the company's financial health and commitment to rewarding shareholders.
Analysts have given Kenvue Inc. an average rating of "Hold" with a price target of $22.10, suggesting a potential for growth and stability in the stock price.
Kenvue Inc. reported earnings per share of $0.32 for the quarter, surpassing the consensus estimate of $0.28 by $0.04, showcasing strong financial performance.
The company has a market capitalization of $44.29 billion, indicating a significant presence in the market and potential for long-term growth.
Kenvue Inc. operates in the consumer health sector worldwide, a resilient industry with steady demand and growth opportunities.

Kenvue
Bear Case

Investors should be bearish about investing in Kenvue Inc. for these reasons:

Despite positive aspects, Kenvue Inc. has received mixed ratings from analysts, with one sell rating and a majority of hold ratings, indicating uncertainty in the stock's performance.
The stock's current price of $23.02 on the NYSE may be considered high by some investors, potentially limiting short-term gains.
With a dividend payout ratio of 105.13%, Kenvue Inc. is distributing more in dividends than its earnings, which could raise concerns about sustainability and future growth.
Recent downgrades by analysts, such as the shift from an "outperform" to a "sector perform" rating, may signal potential challenges or headwinds for the company.
While the company has shown resilience, the consumer health sector can be competitive and subject to regulatory changes, posing risks to Kenvue Inc.'s operations and profitability.

KVUE Forecast - Frequently Asked Questions

: According to the research reports of 12 Wall Street equities research analysts, the average twelve-month stock price forecast for Kenvue is $22.64, with a high forecast of $27.00 and a low forecast of $18.00.
: 12 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Kenvue in the last year. There is currently 1 sell rating, 7 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" KVUE shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in KVUE, but not buy additional shares or sell existing shares.
: According to analysts, Kenvue's stock has a predicted downside of -1.28% based on their 12-month stock forecasts.
: Over the previous 90 days, Kenvue's stock had 1 downgrade by analysts.
: Kenvue has been rated by research analysts at Bank of America, Deutsche Bank Aktiengesellschaft, Jefferies Financial Group, JPMorgan Chase & Co., Piper Sandler, Royal Bank of Canada, and UBS Group in the past 90 days.
: Analysts like Kenvue less than other "consumer staples" companies. The consensus rating score for Kenvue is 2.25 while the average consensus rating score for "consumer staples" companies is 2.43. Learn more on how KVUE compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top Rated Stocks

More Ratings Tools

Election warning coming true… (Ad)

If you missed it, my emergency election broadcast is now available - watch it before it's too late.

Click here to watch it now.

This page (NYSE:KVUE) was last updated on 10/23/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

Get Started with MarketBeat

	Read Your Daily Newsletter
	Check Out My MarketBeat
	Watch Our Tutorial Videos
	Add a Stock to Your Watchlist
	Set Up an Instant Alert
	View a Company's Profile Page
	View Our Financial Calendars
	View Today's Analyst Ratings

Kenvue (KVUE) Stock Forecast & Price Target